Bayer gets warning; Dey loses drugs

> The FDA has expressed concern to Bayer about the testing and quality of pharmaceutical ingredients made at a German facility. Article

> Mylan subsidiary Dey has issued an advisory regarding the theft of two respiratory medications after a tractor-trailer was stolen in Florida. Release

> Drug delivery company OctoPlus will perform process development and clinical manufacturing of Axentis Pharma's lead product, an inhalable treatment for cystic fibrosis. Release

> Ulm, Germany, will host the European Innovation Showcase, an event featuring details of award-winning pharmaceutical manufacturing facilities, in November. Release

> Eli Lilly is creating a Development Center of Excellence to streamline and accelerate late-stage drug development, and says it will reorganize its pharmaceutical business and "significantly reduce" its cost structure by the 2011. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.